Hervycta 150 + Injection
Hervycta 150 + Injection
Trastuzumab (150mg)
Eleftha 150mg Injection
Intas Pharmaceuticals Ltd
Trastuzumab 150mg
Pack Size
vial of 1 injection
Price
Save ₹10700
that's 66% off!
About This Medicine
Product description & overview
Hervycta 150 + Injection: A Targeted Treatment for HER2-Positive Breast Cancer
Hervycta 150 + Injection contains Trastuzumab (150mg), a powerful immunotherapy medication specifically designed to fight certain types of breast cancer. It targets the HER2 protein, which is overexpressed in a subset of tumors known as HER2-positive breast cancers.
This injectable formulation delivers a targeted and precise treatment for:
* Advanced or metastatic HER2-positive breast cancer
* Inoperable or locally advanced HER2-positive breast cancer
Hervycta 150 + Injection is prescribed by qualified healthcare professionals, and its efficacy is supported by extensive clinical trials. The injection provides a direct and potent approach to inhibiting the growth of cancerous cells.
Please note: This description is for informational purposes only. It should not be interpreted as medical advice. Consult with a doctor or pharmacist before using any medication.
Active composition
Trastuzumab 150 mg
About Trastuzumab
Trastuzumab is a monoclonal antibody used to treat HER2-positive breast cancer. It inhibits cancer cell growth and promotes cell death. Its clinical relevance lies in managing specific breast cancer types. In summary, Trastuzumab is essential for treating HER2-positive breast cancer.
How It Works
Trastuzumab binds to the HER2 receptor, inhibiting signaling pathways that promote cancer cell proliferation.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
Hervycta 150 + Injection is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
High Risk
Pregnancy
Hervycta 150 + Injection is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Driving
Hervycta 150 + Injection is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Hervycta 150 + Injection may not be needed in these patients. Please consult your doctor.
Exercise Caution
Breastfeeding
It is not known whether Hervycta 150 + Injection alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Consult Doctor
Kidney
There is limited information available on the use of Hervycta 150 + Injection in patients with liver disease. Please consult your doctor.
Regular Checkup
Customer Reviews
0 reviews for Hervycta 150 + Injection
Products matching your search
Olmezest H 20 Tablet
Olmezest H 20 Tablet
Grinednox-L Capsule
Grinednox-L Capsule
Losanorm 50-H Tablet
Losanorm 50-H Tablet
Glimchek M 2mg/500mg Tablet
Glimchek M 2mg/500mg Tablet
Carispec 6 Capsule
Carispec 6 Capsule
Flunasys-P Tablet SR
Flunasys-P Tablet SR
Calzol-D3 Tablet
Calzol-D3 Tablet
Glz Total Tablet